PainReform is a specialty pharmaceutical company that develops products for the treatment of pain. Focused on reformulations of established pain drugs for the US FDA 505(b)(2) regulatory pathway, PainReform applies unique technologies to enhance efficacy, reduce adverse effects and increase convenience. Our mission is to offer pain therapeutics with clinically meaningful benefits to both physicians and patients.
View Top Employees from PainReform LtdWebsite | http://www.painreform.com |
Ticker | PRFX |
Revenue | $1 million |
Employees | 6 (5 on RocketReach) |
Founded | 2007 |
Address | 65 Yigal Alon St, Tel Aviv, Tel Aviv 6744316, IL |
Phone | +972 9-960-1901 |
Fax | +972 9-954-2266 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Pharmaceuticals, Pharmaceutical Manufacturing, Biopharma, Drug Discovery, Healthcare, Biotechnology, Health Care, Science and Engineering, Pharmaceutical |
Web Rank | 32 Million |
Keywords | Pain Reform Israel |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 325 Companies, NAICS Code 32541 Companies, NAICS Code 32 Companies, NAICS Code 3254 Companies |
Looking for a particular PainReform Ltd employee's phone or email?
The PainReform Ltd annual revenue was $1 million in 2024.
Michael Mulholland is the CEO of PainReform Ltd.
5 people are employed at PainReform Ltd.
PainReform Ltd is based in Tel Aviv, Tel Aviv.
The NAICS codes for PainReform Ltd are [325, 32541, 32, 3254].
The SIC codes for PainReform Ltd are [283, 28].